Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

SecurityCYTK / Cytokinetics, Incorporated
InstitutionCaption Management, LLC
Latest Disclosed Ownership245,000 shares
Latest Disclosed Value $ 16,147,950
Caption Management, LLC ownership in CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 245,000 shares of Cytokinetics, Incorporated (US:CYTK) valued at $16,147,950 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 27,999 shares of Cytokinetics, Incorporated. This represents a change in shares of 775.03% during the quarter. The current value of the position is $17,323,950 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (CYTK) in the form of stock options. The firm currently holds call options representing 1,230,000 of underlying shares valued at $81,069,300 USD and put options representing 381,600 of underlying shares valued at $25,151,256 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 245,000 217,001 775.03 16,148 807.64 0.0943
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 27,999 -2,358 -7.77 1,779 6.65 0.0122
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 30,357 11,357 59.77 1,668 166.03 0.0130
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 19,000 -39,739 -67.65 628 -73.43 0.0069
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 58,739 3,909 7.13 2,361 -8.49 0.0227
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 54,830 21,330 63.67 2,579 45.87 0.0244
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 33,500 -33,500 -50.00 1,769 -51.29 0.0282
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 67,000 -198,554 -74.77 3,630 -80.50 0.0559
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 265,554 -154,805 -36.83 18,618 -46.95 0.2827
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 420,359 405,284 2,688.45 35,096 7,804.28 0.4729
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 15,075 15,075 444 0.0068
2023-05-15 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -100,354 -100.00 0 -100.00
2023-02-14 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 100,354 100,354 4,598 0.0717
2020-11-16 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -61,600 -100.00 0 -100.00
2020-08-14 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 61,600 19,864 47.59 1,452 195.12 0.0484
2020-05-15 2020-03-31 13F CYTOKINETICS COM NEW 23282W605 41,736 41,736 -32.25 492 -66.12 0.0278
2020-02-13 2019-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -14,400 -100.00 0 -100.00
2019-11-14 2019-09-30 13F CYTOKINETICS COM NEW 23282W605 14,400 -15,600 -52.00 164 -51.34 0.0085
2019-08-13 2019-06-30 13F CYTOKINETICS COM NEW 23282W605 30,000 30,000 337 0.0170
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW Call 1,230,000 152.93 81,069 162.37 n/a n/a n/a
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW Call 486,300 64.79 30,900 90.52 n/a n/a n/a
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW Call 295,100 305.91 16,219 575.19 n/a n/a n/a
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW Call 72,700 592.38 2,402 470.55 n/a n/a n/a
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW Call 10,500 -98.09 422 -98.37 n/a n/a n/a
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW Call 548,900 310.55 25,820 265.77 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Call 133,700 59.74 7,059 55.69 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Call 83,700 -82.41 4,535 -86.41 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Call 475,900 -64.80 33,365 -70.44 n/a n/a n/a
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW Call 1,351,900 40,866.67 112,870 116,260.82 n/a n/a n/a
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW Call 3,300 97 n/a n/a n/a
2023-02-14 2022-12-31 13F CYTOKINETICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW Call 60,000 0.00 2,908 23.38 n/a n/a n/a
2022-08-15 2022-06-30 13F CYTOKINETICS COM NEW Call 60,000 100.00 2,357 113.50 n/a n/a n/a
2022-05-13 2022-03-31 13F CYTOKINETICS COM NEW Call 30,000 0.00 1,104 -19.24 n/a n/a n/a
2022-02-11 2021-12-31 13F CYTOKINETICS COM NEW Call 30,000 -73.91 1,367 -66.74 n/a n/a n/a
2021-11-12 2021-09-30 13F CYTOKINETICS COM NEW Call 115,000 150.00 4,110 351.15 n/a n/a n/a
2021-08-16 2021-06-30 13F CYTOKINETICS COM NEW Call 46,000 911 n/a n/a n/a
2021-05-17 2021-03-31 13F CYTOKINETICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F CYTOKINETICS COM NEW Call 32,500 -92.64 675 -92.94 n/a n/a n/a
2020-11-16 2020-09-30 13F CYTOKINETICS COM NEW Call 441,500 11,832.43 9,558 10,761.36 n/a n/a n/a
2020-08-14 2020-06-30 13F CYTOKINETICS COM NEW Call 3,700 88 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW Put 381,600 4,236.36 25,151 4,399.28 n/a n/a n/a
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW Put 8,800 0.00 559 15.73 n/a n/a n/a
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW Put 8,800 -69.44 484 -49.21 n/a n/a n/a
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW Put 28,800 227.27 952 169.41 n/a n/a n/a
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW Put 8,800 -63.03 354 -68.45 n/a n/a n/a
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW Put 23,800 -87.69 1,120 -89.04 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Put 193,300 -3.35 10,206 -5.81 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Put 200,000 -75.11 10,836 -80.76 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Put 803,500 -52.42 56,333 -60.04 n/a n/a n/a
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW Put 1,688,600 1,684.99 140,981 4,960.34 n/a n/a n/a
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW Put 94,600 2,787 n/a n/a n/a
2023-02-14 2022-12-31 13F CYTOKINETICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW Put 60,000 100.00 2,908 146.65 n/a n/a n/a
2022-08-15 2022-06-30 13F CYTOKINETICS COM NEW Put 30,000 0.00 1,179 6.79 n/a n/a n/a
2022-05-13 2022-03-31 13F CYTOKINETICS COM NEW Put 30,000 0.00 1,104 -19.24 n/a n/a n/a
2022-02-11 2021-12-31 13F CYTOKINETICS COM NEW Put 30,000 0.00 1,367 27.52 n/a n/a n/a
2021-11-12 2021-09-30 13F CYTOKINETICS COM NEW Put 30,000 1,072 n/a n/a n/a
2021-02-16 2020-12-31 13F CYTOKINETICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F CYTOKINETICS COM NEW Put 370,000 8,010 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.